Nadia Peragine

Pubblicazioni

Titolo Pubblicato in Anno
Rapid identification of BCR/ABL1-like acute lymphoblastic leukaemia patients using a predictive statistical model based on quantitative real time-polymerase chain reaction: clinical, prognostic and therapeutic implications. BRITISH JOURNAL OF HAEMATOLOGY 2018
Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib BRITISH JOURNAL OF HAEMATOLOGY 2018
IL7R overexpression in adult acute lymphoblastic leukemia is associated to JAK/STAT pathway mutations and identifies patients who could benefit from targeted therapies LEUKEMIA & LYMPHOMA 2018
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes ONCOTARGET 2016
RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications HAEMATOLOGICA 2016
The antileukemic potential of natural killer cells IMMUNOTHERAPY 2016
Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients. CANCER IMMUNOLOGY, IMMUNOTHERAPY 2015
Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212. GENES, CHROMOSOMES & CANCER 2015
A good manufacturing practice method to ex vivo expand natural killer cells for clinical use. BLOOD TRANSFUSION 2015
CD45 antigen negativity in T-lineage ALL correlates with PTPRC mutation and sensitivity to a selective JAK inhibitor. BRITISH JOURNAL OF HAEMATOLOGY 2015

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma